| |
Squamous cell carcinoma |
20/201, 4/4(cytological
specimens with the line of differentiation subsequently determined
by biopsy or excision specimens)1,
13/152 |
2/201 , 0/4(cytological
specimens with the line of differentiation subsequently determined
by biopsy or excision specimens)1 |
|
Adenocarcinoma |
1/201, 0/20(cytological
specimens with the line of differentiation subsequently determined
by biopsy or excision specimens)1,
0/29(using
cell blocks from FNA samples, correlated with subsequent surgical
specimens.) 2
|
18/201, 7/20(cytological
specimens with the line of differentiation subsequently determined
by biopsy or excision specimens in which 16/20 were positive)1 |
|
Large cell carcinoma |
27/491,
1/7 (cytological
specimens with the line of differentiation subsequently determined
by biopsy or excision specimens in which 2/7 were positive) 1 |
2/12(using cell blocks
from FNA samples, correlated with subsequent surgical specimens.)
2 |
24/49(staining
for Desmocollin-3 and TTF-1 were mutually exclusive)1, 1/7(cytological
specimens with the line of differentiation subsequently determined
by biopsy or excision specimens in which 5/7 were positive)1 |
3/12(using cell blocks
from FNA samples, correlated with subsequent surgical specimens.)
2
|
|